Obs & Paeds Flashcards
Obstetric critical care admissions
83% postnatal
Haemorrhage, sepsis, pre-eclampsia commonest
Antepartum - covid, respiratory failure
Fetal considerations in maternal critical care
monitoring
- obstetric and midwifery teams
- CTG / auscultation / dopplers as indicated
Delivery
- timing decided by MDT
- mother may benefit if intractable hypoxia
- lung maturation with steroids 24-34 weeks
resuscitation
- specialised equipment
teratogencity
- imaging risks
- drug risks 1st trimester
Risks of imaging
fetus maximum risk 10 - 17 weeks from ionising radiation (microcephaly, developmental delay)
iodine - fetal thyroid risk worse with age
mother CTPA - risk of breast cancer. V/Q increased risk to fetus
pharmacological concerns
- teratogenicity 1st trimester - AEDs, warfarin, ACE, antibiotics (trimethoprim, tetracyclines)
- Analgesics - NSAIDs - closure of DA, avoid after 30/40, codeine unreidvtable breastfeeding, opioids neonatal resp depression and withdrawal
- sedatives - depressant effect on fetus at delivery
Hypertensive disease in pregnancy
10% pregnancies
neonatal and maternal morbidity and mortality
gestation hypertension / PIH
> 140/90 after 20/40
- aim for < 135/85
- methyldopa
- labetalol
- nifedipine
- Ix for PET
160/110
- admit to hospital
PET
> 140 / 90
20/40
Organ dysfunction
- proteinuria (PCR > 30mg/mmol) / 2+
- creatinine > 90
- headache
- ALT 2x ULN
- platelets < 150
- IUGR
Severe PET features
> 160 / 110
Pulmonary oedema
Eclamptic seizures
RUQ pain
HELLP
platelet < 100
severe headache, visual disturbance
PET pathophysiogy
complex multi-system disease associated with endothelial dysfunction
abnormal placentation, relative placental hypoxia
- inflammatory factors
decrease proangiogenic (VEGF)
increase antiangiogenic
increased vascular tone and permeability
PET MX
- BP control - methyldopa, labetalol, nifedipine
- labetalol 200mg 12hrly increased to 2.4g/24hr
- IV bolus 20mg then commence infusion
- Aim for < 135/95
- MgSo4 seizure or severe. 4g bolus then 1g/hr. tendon reflexes. toxicity - calcium.
- MAGPIE - lower risk of eclampsia
- consideration of invasive monitoring
- monitoring for end organ complications - U+E / LFT / Coag studies
- If severe –> delivery. dependent on gestation, severity
- careful fluid balance (1ml/kg/hr)
PET Complications
- eclamptic seizures
- severe organ dysfunction - liver, renal, DIC
- hypertensive emergencies - aortopathy, ACS, ICH
- fluid leak - pulmonary oedema
- fetal compromise - IUGR, death, preterm birth
- PPH
PET admission to critical care
- features of severe disease
- pulm oedema requiring respiratory support
- severe hypertension requiring IV
- eclamptic seizures
- strict fluid balance, severe ologuria
- severe coagulopathy needing mx
- Bleeding / PPH
considerations
- difficult airway
- hypertensive response to laryngoscopy
- risk of pulmonary oedema - restrictive balance, GTN
Major obstetric haemorrhage
9% perinatal deaths (50% worldwide)
Classification
Antepartum 24/40 - delivery
- abruption, praaevia, trauma, accreta, rupture
Postpartum
- primary - 24hrs
- secondary 24hrs-12 weeks - infection
- minor 500-1L
- major > 1L. moderate 1L-2L. severe > 2L
WHO maternal sepsis
life threatening organ dysfunction resulting from infection during pregnancy, childbirth, post-abortion or postpartum period
leading cause of maternal morbidity and mortality worldwide. UK 11% deaths.
Common causes maternal sepsis
Direct
- Genital tract infection - Group A strep
- endometritis - e.coli
indirect
- urinary tract infection
- respiratory
- meningitis
- covid
risk factors maternal sepsis
patient
- immunocompromise - medications, diabetes
- ivdu
- strep colonised
pregnancy / delivery related
- IUD
- pph
- instrumentation
- prolonged labour
- PROM
- retained products
- trauma
- c-section
Management priorities in maternal sepsis
prevention - vaccination, abx for instrumentation, management of PROM
cvs support - left lateral displacement fluid management
surgical source control - wound infection, ERPC, delivery of fetus
considerations re. delivery - source, severity, gestation age, fetal wellbeing, state of labour, parity
AFE
exposure of fetal antigens or amniotic fluid substances to maternal circulation leads to sudden catastrophic immune activation
2 phases
- initial entry of substances leads to pulmonary hypertension, RV failure, microvascular damage, hypotension
- LV failure, endothelial activation, capillary leak, DIC
high mortality, neurological injury
AFE presentation
- fetal distress
- sudden profound maternal collapse
- cardiac arrest
- hypotension
- pulmonary oedema, ards, hypoxia
- seizures
- dic
clinical diagnosis, confirmation postmortem only
acute hypotension, cardiac arrest, hypoxia, coagulopathy, haemorrhage in absence of other explanation
DDX anaphylaxis, PE, MI, sepsis, LAST, major haemrrhage
risk factors for AFE
advanced age, eclampsia, multiple pregnancy, male fetus, induction, oxytopicin, c-section
Causes of maternal cardiac arrest
Hypoxia
- PE
- AFE
- Pulmonary oedema
Hypovolaemia
- Haemorrhage
- Sepsis
Hypo/hyperkalaemia
hypothermia rare
toxins - LAST
Tamponade: aortic dissection
Thrombosis: AFE, PE
Tension
Alterations in ALS for maternal cardiac arrest
- left uterine displacement
- perimortem cesarean - within 5 mins
Specific drugs - MgSO4 for eclampsia
- calcium for magnesium toxicitiy
- thrombolysis
- intralipid
MBRACCE 2019-21
Indirect causes
1. covid-19
2. Cardiac disease
3. Neurological
4. Sepsis
5. Psychiatric
Direct causes
1. Thrombosis
2. Haemorrhage
3. Psychiatric
4. Sepsis
5. PET
6. AFE
Direct = resulting from obstetric complications of the pregnant state, including interventions, omissions, treatment
Indirect = resulting from previous existing disease or disease that developed during pregnancy, not due to direct obstetric causes but aggravated by physiological changes of pregnancy
bronchiolotis
respiratory infection, children under 2 (3-6mo)
clinical diagnosis
coryza, fever, wheeze, cough, crepitations
varying respiratory failure
DDx pneumonia, croup, asthma, viral wheeze
Severe disease
- FiO2 > 0.5 to maintain 95%
- severe recessions
- tachypnoea, tachycardia, apnoeas
Life threatening
- Sats < 88% despite HF / CPAP
- respiratory acidosis
- apnoeas requiring FMV, exhaustion, grunting
risk factors in bronchiolitis
- chronic lung disease
- prematurity
- cardiac comorbidity
- < 6 weeks of age
Mx bronchiolotis
- clear nasal secretions
- respiratory support - humidified O2, CPAP, BIPAP
- hydration / NG feed
- gastric decompression
- invasive ventilation
- deteriorating severe disease
- respiratory acidosis, hypoxia on NIV
ICU complciations
- secondary bacterial infection
- mucous plugging
- bronchospasm
- bradycardia
- hyponatraemia